Allergic contact dermatitis caused by isobornyl acrylate in the Enlite glucose sensor and the Paradigm MiniMed Quick‐set insulin infusion set

Anne Herman,Marie Baeck,Laurence Montjoye,Magnus Bruze,Emil Giertz,An Goossens,Martin Mowitz
DOI: https://doi.org/10.1111/cod.13374
2019-08-27
Contact Dermatitis
Abstract:<h3 class="article-section__sub-title section1"> Background</h3><p>The FreeStyle Libre glucose sensor has caused many cases of allergic contact dermatitis, and isobornyl acrylate (IBOA) was identified as one of the culprit allergens.</p><h3 class="article-section__sub-title section1"> Objectives</h3><p>To report on the presence of IBOA in devices produced by Medtronic, i.e., Enlite sensor and insulin infusion set Paradigm MiniMed Quick‐Set.</p><h3 class="article-section__sub-title section1"> Patients and Methods</h3><p>Five patients reacting to the glucose sensor Enlite and/or the insulin infusion set Paradigm MiniMed Quick‐Set observed in three clinics (two Belgian, one Swedish) were patch tested with the baseline and other series, as well as with IBOA; four of them also to pieces of adhesive patches from the devices, and two with a thin layer chromatogram of Enlite glucose sensor extracts. Gas chromatography–mass spectrometry analyses were performed.</p><h3 class="article-section__sub-title section1"> Results</h3><p>Four patients reacted to IBOA and one to colophonium, a known allergen in Enlite, and three to the adhesive part of the sensor or the insulin infusion set. IBOA was identified by GC–MS in the sensor, and its presence was indicated in the infusion set.</p><h3 class="article-section__sub-title section1"> Conclusions</h3><p>IBOA is also a contact allergen in Enlite glucose sensor, and likely also in the infusion set. Therefore, these devices are not suitable alternatives for patients sensitised to the FreeStyle Libre sensor.</p><p>This article is protected by copyright. All rights reserved.</p>
dermatology,allergy
What problem does this paper attempt to address?